CN101234153A - Externally-applied medicament for treating bone fracture - Google Patents
Externally-applied medicament for treating bone fracture Download PDFInfo
- Publication number
- CN101234153A CN101234153A CNA2007101162145A CN200710116214A CN101234153A CN 101234153 A CN101234153 A CN 101234153A CN A2007101162145 A CNA2007101162145 A CN A2007101162145A CN 200710116214 A CN200710116214 A CN 200710116214A CN 101234153 A CN101234153 A CN 101234153A
- Authority
- CN
- China
- Prior art keywords
- medicine
- fracture
- bone fracture
- treatment
- days
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
The invention discloses a medicine for external use for treating bone fracture, which comprises Drynaria fortunei, snake steeping gold, salt frost cypress, natural copper, safflower, Gendarussaventricosa, japanese teasel, Glechoma longituba (Nakai) Kupr, frankincense, myrrh, hillock Japanese apricot, Psychotria rubra (Lour.) Poir., Sambucus williamsii Hance and muskiness. The medicine is acquired by processing the raw materials into a Chinese traditional medicine powder preparation with fine powders (more than 200 mesh). The medicine of the invention can be used according to the following steps: shaping and reduction the bones, then mixing the powder of the medicine of the invention (with proper amount) with right amount of leaf lard to be an ointment, applying on the affected part with a thickness of 2-3mm and well binding up, and then fixing well with plywood, changing the medicine once three days, thus the bone fracture recovers after 3-9 days. The medicine has remarkable effect, no toxic and side effect with an effective rate of 100 percent and a cure rate of 96 percent.
Description
Technical field
The present invention relates to a kind of external used medicine for the treatment of fracture, specifically is a kind of external used medicine for the treatment of fracture of preparation of raw material with the Chinese herbal medicine.
Background technology
The many effects of fracture because of external force, as own traumatic injury or damage that to cause fracture, cardinal symptom be local stasis of blood, swell and ache, misplace, deformity, bone sound, abnormal movement and axle center percussion pain etc.Western medicine adopts transfusion to add anti-inflammation class medicine (as penicillin, gentamycin) treatment more at present, and integration resets, mainly by self-recovery, and conservative treatment, very the person takes operative treatment to bring the hardship of broadsword play and burden economically to patient.(SHEXIANG JIEGU JIAONANG) that Chinese medicine then adopts Jilin Province Luo Bang pharmaceutcal corporation, Ltd to go out take because of medicine time long, healing time is long, effect is undesirable; Utilize Cortex erythrinae soup (the full mirror of doctor ancestor) washout, need long-time washout, bring unnecessary trouble and misery to patient, its effect is also undesirable.
The invention reside in provides a kind of external used medicine for the treatment of fracture.The purpose of invention is blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain, and invigorating the kidney and strengthening the bones, reunion of bone, thus dredge the meridian passage reaches the purpose of quickly treating fracture.
Summary of the invention
Solution of the present invention is based on the fracture and the Therapeutic Principle of motherland's traditional medicine, with reference to modern pharmacological research, select invigorating the liver and kidney, bone and muscle strengthening for use, invigorate blood circulation, reducing swelling and alleviating pain, promoting tissue regeneration by removing blood stasis, synthetism granulation promoting, promoting blood circulation to restore menstrual flow class medicine are formulated by theory of Chinese medical science, can improve the blood circulation of fracture, accelerate the healing of fracture, reach the purpose of rapid heal fractures.
Prescription of the present invention and raw material deal are as follows:
Rhizoma Drynariae 10-20, SHEPAOJIN 12-30, salt efflorescence cypress 12-30, Pyritum 15-30, Eupolyphaga Seu Steleophaga 10-30, Flos Carthami 10-20, Ramulus Et Folium Adhatodae Vasicae 12-30, Radix Dipsaci 20-30, Radix seu Folium Gaultheriae Forrestii 12-30, Olibanum 15-30, Myrrha 15-30, Flos Ilicis Asprellae 10-18, Red Psychotria Leaf 15-24, Herba sambuci chinensis 12-18, Moschus 1-3.
Prescription of the present invention and optimum feed stock deal are:
Rhizoma Drynariae 15, SHEPAOJIN 15, salt efflorescence cypress 15, Pyritum 20, Flos Carthami 15, Ramulus Et Folium Adhatodae Vasicae 15, Radix Dipsaci 20, Radix seu Folium Gaultheriae Forrestii 15, Olibanum 25, Myrrha 25, Flos Ilicis Asprellae 18, Red Psychotria Leaf 24, Herba sambuci chinensis 18, Moschus 2.5.
It is obvious to use Drug therapy curative effect of fracture of the present invention, can make union of fracture rapid, short treating period, and good effect has no side effect, and is non-stimulated, and effective percentage reaches 100%, and cure rate reaches 96%.
Drug action mechanism of the present invention is as follows:
Rhizoma Drynariae: bitter in the mouth, warm in nature.Go into kidney, heart channel.Have the kidney invigorating, reuniting the fractured tendons and bones, treat the merit of folding wound, cure mainly the injury and bone fracture injury of tendon and muscle.See (middle hospital pharmacy), the Guangdong college of traditional Chinese medicine compiles, the People's Health Publisher, Guangdong.The first impression in August, 1973.(seeing 631 pages)
SHEPAOJIN: lightly seasoned, puckery, cold nature.Merit with blood circulation promoting and blood stasis dispelling, synthetism granulation promoting.(the same, as to see 567)
Salt efflorescence cypress: salty in the mouth, acid, cold nature.Merit with promoting tissue regeneration by removing blood stasis, reunion of fractured tendons and bones.(the same, as to see 572 pages)
Radix Dipsaci: bitter in the mouth, little suffering, warm in nature.Go into liver, kidney channel.Merit with invigorating the liver and kidney, bone and muscle strengthening.Being mainly used to treat wound muscles and bones fractures.(the same, as to see 621 pages)
Radix seu Folium Gaultheriae Forrestii: acrid in the mouth, sweet, cold nature.Merit with blood circulation promoting and blood stasis dispelling, synthetism granulation promoting.(the same, as to see 566 pages)
Pyritum: acrid in the mouth, property is flat.Go into Liver Channel.Merit with eliminating stasis to stop pain.Cure mainly treating swelling and pain by traumatic injury, the exogenous injury stasis of blood pain that stagnates.(the same, as to see the 560-561 page or leaf)
Flos Carthami, acrid in the mouth, warm in nature.Go into the heart, Liver Channel.Has promoting blood circulation to restore menstrual flow, the merit of stasis-dispelling and pain-killing.Be mainly used in the wound pain due to blood stasis.(the same, as to see 549 pages)
Ramulus Et Folium Adhatodae Vasicae: sour in the mouth, suffering, property is flat.Merit with blood circulation promoting and blood stasis dispelling, reunion of fractured tendons and bones.(the same, as to see 571 pages)
Olibanum: bitter in the mouth, suffering, gas perfume (or spice) warm in nature.Go into the heart, liver, spleen channel.Has blood-activating and qi-promoting, the merit of relaxing muscles and tendons and activating QI and blood in the collateral, alleviating pain and detumescence granulation promoting.Be used for traumatic injury stasis of blood pain, QI and blood is condensed.(the same, as to see 546 pages)
Myrrha: bitter in the mouth, property is flat.Gas fragrance.Go into Liver Channel.Has blood circulation promoting and blood stasis dispelling, the merit of subduing swelling and relieving pain.Be used for traumatic injury stasis of blood pain.(the same, as to see 547 pages)
Flos Ilicis Asprellae: sweet in the mouth, little hardship, cool in nature.Merit with dissipating blood stasis for subsidence of swelling pain relieving.Be used for traumatic injury stasis of blood pain.(the same, as to see 142 pages)
Red Psychotria Leaf: bitter in the mouth, cold nature.Merit with synthetism granulation promoting.Be used for traumatic injury.(the same, as to see 204 pages)
Herba sambuci chinensis: sweet in the mouth, light, property is flat.Merit with stasis-dispelling and pain-killing.The power of this product stasis-dispelling and pain-killing is very strong, is mainly used to traumatic injury.(the same, as to see 370 pages)
Moschus: acrid in the mouth, warm in nature.Go into the heart, spleen channel.Has fragrant inducing resuscitation, the merit of promoting blood circulation to remove blood stasis.Be used for traumatic injury, inducting the medicines into affected channel.(the same, as to see 718 pages)
All medicines are synthetic to have invigorating the liver and kidney, strengthening bone and muscle, promoting blood circulation and detumescence, and stasis-dispelling and pain-killing, reunion of bone, the effect of promoting blood circulation to remove obstruction in the collateral reaches the purpose of rapid heal fractures.
Theory of Chinese medical science is thought fracture, and how because of external force, myotility causes blocking of bone, cataclasm or oblique fracture.Mainly show as local stasis of blood, swell and ache, misplace, deformity, bone sound, abnormal movement and axle center tunk pain etc.
The present invention fills out marrow with the kidney invigorating, and reunion of fractured tendons and bones is the rule of treatment,, reuses with Olibanum, Myrrha, Herba sambuci chinensis, promoting blood circulation to disperse blood clots and relieves pain for setting about with the promoting blood circulation and detumescence pain relieving, and is inducing diuresis and reducing edema; SHEPAOJIN, Ramulus Et Folium Adhatodae Vasicae, salt efflorescence cypress, Pyritum, Eupolyphaga Seu Steleophaga, Flos Carthami, Flos Ilicis Asprellae, Red Psychotria Leaf blood circulation promoting and blood stasis dispelling, detumescence dissipating blood stasis, synthetism granulation promoting; Radix Dipsaci, Rhizoma Drynariae, invigorating the liver and kidney, strengthening bone and muscle; The Moschus antiinflammatory, synthetism, inducting the medicines into affected channel.All medicines mutually and, mutually easily cite, have invigorating the kidney and strengthening the bones, blood circulation promoting and blood stasis dispelling, the effect of reducing swelling and alleviating pain, synthetism granulation promoting reaches the purpose of rapid heal fractures.
The specific embodiment
The invention will be further described below in conjunction with embodiment:
Embodiment: get: Rhizoma Drynariae 15, SHEPAOJIN 15, salt efflorescence cypress 15, Pyritum 20, Flos Carthami 15, Ramulus Et Folium Adhatodae Vasicae 15, Radix Dipsaci 20, Radix seu Folium Gaultheriae Forrestii 15, Olibanum 25, Myrrha 25, Flos Ilicis Asprellae 18, Red Psychotria Leaf 24, Herba sambuci chinensis 18, Moschus 2.5.Above raw material is processed into micropowder (more than 200 orders) Chinese medicine powder altogether.
Drug use method of the present invention: the shaping of will fracturing earlier resets, and an amount of and deposited affected part of drug powder of the present invention (in right amount) the furnishing cream 2-3 millimeters thick with Ovum Gallus domesticus album bandages then, fixes with clamping plate then, changes medicine one time in 3 days, and fracture promptly healed in 3-9 days.
For showing the curative effect of medicine of the present invention, 100 routine fracture patients are carried out clinical observation, test group Drug therapy of the present invention; Matched group is therapy for treating routinely, mainly adopts penicillin, infuses and takes (SHEXIANG JIEGU JIAONANG) that Jilin Province Luo Bang pharmaceutcal corporation, Ltd goes out and utilize the treatment of Cortex erythrinae soup (Yizong Jinjian) washout.Adopt identical method to make regular check on, be viewed as 10 days.3 days is a course of treatment, totally 3 courses of treatment is effectively with the sx, and transference cure can ownly be walked not feels pain for fully recovering.The result represents:
1, test group 50 examples, wherein open fracture 24 examples, closed fracture 26 examples, male 33 examples, women 17 examples, age 5-70 year, course of disease 2-5 days.Through fully recover with Drug therapy of the present invention, open fracture fracture 3 courses of treatment 22 examples, effective 2 examples; Closed fracture 26 examples of fully recovering 1 course of treatment; Total effective rate 100%, cure rate 96%.
2, matched group 50, wherein open fracture 12 examples, closed fracture 38 examples, male 30 examples, women 20 examples, age 4-65 year, course of disease 1-4 days.Therapy for treating routinely mainly adopts penicillin, infuses and takes (SHEXIANG JIEGU JIAONANG) that Jilin Province Luo Bang pharmaceutcal corporation, Ltd goes out and utilizes the treatment of Cortex erythrinae soup (Yizong Jinjian) washout.Open fracture 6 examples of fully recovering 3 courses of treatment, effective 2 examples; Closed fracture 1 course of treatment fully recovers 18, effective 5 examples.Total effective rate 62%, cure rate 48%.
Result of the test shows, through with medicine of the present invention 50 fracture patients being made clinical trial, has obtained significant curative effect, effective percentage 100%, cure rate 96%.
The best way that the present invention realizes is got the high-quality raw material of Chinese medicine by the prescription deal of embodiment and is processed into micropowder (more than 200 orders) Chinese medicine powder, and it is standby to receive bottle then.
Claims (2)
- The external used medicine of 1, treatment fracture is characterized in that: the external used medicine that it is made up of the deal of following raw material prescription proportioning: Rhizoma Drynariae 10-20, SHEPAOJIN 12-30, salt efflorescence cypress 12-30, Pyritum 15-30, Eupolyphaga Seu Steleophaga 10-30, Flos Carthami 10-20, Ramulus Et Folium Adhatodae Vasicae 12-30, Radix Dipsaci 20-30, Radix seu Folium Gaultheriae Forrestii 12-30, Olibanum 15-30, Myrrha 15-30, Flos Ilicis Asprellae 10-18, Red Psychotria Leaf 15-24, Herba sambuci chinensis 12-18, Moschus 1-3.
- 2, a kind of external used medicine for the treatment of fracture according to claim 1 is characterized in that: the external used medicine that it is made up of the best deal of following raw material prescription proportioning: Rhizoma Drynariae 15, SHEPAOJIN 15, salt efflorescence cypress 15, Pyritum 20, Flos Carthami 15, Ramulus Et Folium Adhatodae Vasicae 15, Radix Dipsaci 20, Radix seu Folium Gaultheriae Forrestii 15, Olibanum 25, Myrrha 25, Flos Ilicis Asprellae 18, Red Psychotria Leaf 24, Herba sambuci chinensis 18, Moschus 2.5.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101162145A CN101234153B (en) | 2007-12-27 | 2007-12-27 | Externally-applied medicament for treating bone fracture |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2007101162145A CN101234153B (en) | 2007-12-27 | 2007-12-27 | Externally-applied medicament for treating bone fracture |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN101234153A true CN101234153A (en) | 2008-08-06 |
| CN101234153B CN101234153B (en) | 2010-11-10 |
Family
ID=39918220
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2007101162145A Expired - Fee Related CN101234153B (en) | 2007-12-27 | 2007-12-27 | Externally-applied medicament for treating bone fracture |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101234153B (en) |
Cited By (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637549B (en) * | 2009-08-13 | 2011-02-09 | 王少云 | Medicine for treating fracture |
| CN103230437A (en) * | 2013-05-08 | 2013-08-07 | 杨建生 | Chinese herbal medicine application for treating fracture and preparation method thereof |
| CN104099045A (en) * | 2013-04-09 | 2014-10-15 | 日东电工株式会社 | Adhesive composition and adhesive sheet |
| EP2747573A4 (en) * | 2011-08-24 | 2015-04-01 | Avon Prod Inc | Collagen and elastin stimulating compositions and uses thereof |
| CN104491049A (en) * | 2015-01-15 | 2015-04-08 | 贺国瑞 | Traditional Chinese medicine composition for treating exudative pleural effusion |
| US9238000B2 (en) | 2012-12-11 | 2016-01-19 | Avon Products, Inc. | Method of improving aging appearance of skin by modulation of WIPI-1 |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103285109A (en) * | 2012-02-29 | 2013-09-11 | 许春付 | Chinese herbal medicine for treating bone fracture and preparation method thereof |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100394955C (en) * | 2006-08-02 | 2008-06-18 | 朴喜新 | Chinese traditional medicine preparation for treating bone fracture and traumatic injury |
| CN100551390C (en) * | 2006-12-06 | 2009-10-21 | 洪之伦 | The medicine for external use of treatment fracture |
-
2007
- 2007-12-27 CN CN2007101162145A patent/CN101234153B/en not_active Expired - Fee Related
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101637549B (en) * | 2009-08-13 | 2011-02-09 | 王少云 | Medicine for treating fracture |
| EP2747573A4 (en) * | 2011-08-24 | 2015-04-01 | Avon Prod Inc | Collagen and elastin stimulating compositions and uses thereof |
| US10195136B2 (en) | 2011-08-24 | 2019-02-05 | Avon Products, Inc. | Collagen and elastin stimulating compositions and uses thereof |
| US9238000B2 (en) | 2012-12-11 | 2016-01-19 | Avon Products, Inc. | Method of improving aging appearance of skin by modulation of WIPI-1 |
| CN104099045A (en) * | 2013-04-09 | 2014-10-15 | 日东电工株式会社 | Adhesive composition and adhesive sheet |
| CN104099045B (en) * | 2013-04-09 | 2017-12-26 | 日东电工株式会社 | Adhesive composition and bonding sheet |
| CN103230437A (en) * | 2013-05-08 | 2013-08-07 | 杨建生 | Chinese herbal medicine application for treating fracture and preparation method thereof |
| CN103230437B (en) * | 2013-05-08 | 2015-06-03 | 杨建生 | Chinese herbal medicine application for treating fracture and preparation method thereof |
| CN104491049A (en) * | 2015-01-15 | 2015-04-08 | 贺国瑞 | Traditional Chinese medicine composition for treating exudative pleural effusion |
Also Published As
| Publication number | Publication date |
|---|---|
| CN101234153B (en) | 2010-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102488869B (en) | Traditional Chinese medicinal external-use liniment for muscle and bone ache | |
| CN102266541B (en) | Chinese medicinal plaster for treating hyperosteogeny or hyperosteogeny pain | |
| CN1634225A (en) | Medicine for reducing swelling, easing pain, promoting bone reunion and the preparation process thereof | |
| CN101234153B (en) | Externally-applied medicament for treating bone fracture | |
| CN101062194B (en) | Medicine for treating bone disease and fracture and the preparing method thereof | |
| CN101007040B (en) | External applied medicine for treating bone fractures | |
| CN101637549B (en) | Medicine for treating fracture | |
| CN104225249A (en) | Oral-administration fracture-setting traditional Chinese medicine for treating fracture | |
| CN1112206C (en) | Bone fracture setting medicine powder | |
| CN100534480C (en) | Bone-setting medicine and preparation method thereof | |
| CN1454660A (en) | Bone-setting medicine | |
| CN106362066A (en) | Medicinal liquor for treatment of rheumatic and rheumatoid diseases and preparation method thereof | |
| CN106421255B (en) | External Chinese herbal medicine composition and application thereof | |
| CN1267127C (en) | Osteoproliferation medicine for external application | |
| CN109966451A (en) | A kind of Chinese medicine composition of bone-setting and pain-relieving | |
| CN101342287A (en) | Medical ointment for quickly knitting bone, relaxing tendons, and activating blood circulation, removing stasis, and preparation method thereof | |
| CN1290540C (en) | Oral admnistration Chinese medicine for treating bone fracture and matched topically applied Chinese medicine | |
| CN104800443A (en) | Bone setting agent with functions of tonifying kidney and regenerating bone marrow | |
| CN1127966C (en) | 'Hehe' ointment and its preparing process | |
| CN108888736B (en) | External-use bone reunion medicine and preparation method thereof | |
| CN101953908A (en) | Chinese medicinal composition for treating pain in waist and lower extremities and preparation method thereof | |
| CN105853760A (en) | Orthopedic plaster and preparation method thereof | |
| CN104666653A (en) | Traditional Chinese medicine ointment for treating arthritis of knee cap and preparation method of traditional Chinese medicine ointment | |
| CN1814080A (en) | External-use medicine for treating protrusion of intervertebral disc and hyperosteoguey | |
| CN101322754B (en) | Medicine for curing bone fracture |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LU XU Free format text: FORMER OWNER: JIANG BAOZHEN Effective date: 20100524 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Lu Xu Inventor after: Dai Ping Inventor after: Jiang Xiuqing Inventor after: Xing Yanling Inventor after: Lu Xu Inventor before: Jiang Baozhen |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: JIANG BAOZHEN TO: LU XU LU PING JIANG XIUQING XING YANLING LU XU Free format text: CORRECT: ADDRESS; FROM: 252300 (ZHENXING ROAD), YANGGU COUNTY SCIENCE AND TECHNOLOGY BUREAU, LIAOCHENG CITY, SHANDONG PROVINCE TO: 252100 OBSTETRICS AND GYNECOLOGY DEPARTMENT, RENMIN HOSPITAL, NO.136, WENHUA ROAD, CHIPING COUNTRY, SHANDONG PROVINCE |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20100524 Address after: 252100 obstetrics and Gynecology, 136 people's Hospital, Wenhua Road, Shandong, Chiping Applicant after: Lu Xu Address before: 252300 science and Technology Bureau of Yanggu County, Shandong, Liaocheng province (Zhenxing Road) Applicant before: Jiang Baozhen |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| C17 | Cessation of patent right | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20101110 Termination date: 20101227 |